SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,382.47 472.77
( 0.66%)

Global Indices

Nasdaq

51,190.24 242.68
(0.48%)

Dow Jones

7,742.36 54.91
(0.71%)

Hang Seng

69,916.07 1,606.61
(2.35%)

Nikkei 225

10,455.36 27.09
(0.26%)

Forex

USD-INR

96.17 0.25
(0.26%)

EUR-INR

108.49 -0.30
(-0.28%)

GBP-INR

127.16 -0.03
(-0.02%)

JPY-INR

0.61 0.00
(-0.36%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Trident Lifeline Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543616

INE0MKA01014

83.4000167

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

22.92

450

EPS(TTM)

Face Value()

Div & Yield %

16.42

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	101.90	67.80	44.65	31.69	21.77	9.62
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	101.90	67.80	44.65	31.69	21.77	9.62
Other Income	4.17	3.14	2.20	1.15	0.60	0.16
Stock Adjustments	1.95	-1.47	0.67	2.89	0.46	0.41
Total Income	108.02	69.47	47.52	35.73	22.83	10.19
EXPENDITURE :
Raw Materials	64.23	34.74	30.23	23.12	14.69	5.92
Power & Fuel Cost	0.23	0.14	0.07	0.03	0.02	0.02
Employee Cost	2.94	2.51	1.55	1.39	1.10	0.70
Other Manufacturing Expenses	7.99	8.73	2.54	2.38	2.66	1.29
Selling & Administrative Expenses	2.92	1.76	1.36	0.98	0.94	0.83
Miscellaneous Expenses	1.19	0.79	0.70	0.42	0.11	0.01
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	79.50	48.66	36.45	28.33	19.52	8.78
Operating Profit	28.52	20.81	11.08	7.42	3.32	1.41
Interest	1.68	1.38	0.51	0.48	0.13	0.41
Gross Profit	26.84	19.43	10.57	6.94	3.19	1.00
Depreciation	1.86	1.53	0.77	0.36	0.20	0.14
Profit Before Tax	24.98	17.90	9.80	6.58	2.99	0.86
Tax	6.40	4.25	2.38	0.04	-0.14	0.00
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.49	0.60	0.37	0.52	-0.82	0.22
Reported Net Profit	18.09	13.05	7.04	6.01	3.95	0.63
Extraordinary Items	-0.01	0.00	0.01	0.00	0.00	0.00
Adjusted Net Profit	18.10	13.05	7.03	6.01	3.95	0.63
Adjustment below Net Profit	0.00	0.00	0.00	-0.50	0.00	-0.63
P & L Balance brought forward	22.38	9.33	2.29	-3.22	-7.17	-6.10
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	-0.63
P & L Balance carried down	40.48	22.38	9.33	2.29	-3.22	-5.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	15.16	11.35	6.13	5.23	4.93	1.26
Earnings Per Share(Adj)-Unit Curr	15.16	11.35	6.13	5.23	4.93	1.26
Book Value-Unit Curr	79.91	57.16	45.81	39.68	5.97	-0.94
Book Value(Adj)-Unit Curr	79.91	57.16	45.81	39.68	5.97	-0.94

72,382.47 472.77 ( 0.66%)

51,190.24 242.68 (0.48%)

7,742.36 54.91 (0.71%)

69,916.07 1,606.61 (2.35%)

10,455.36 27.09 (0.26%)

96.17 0.25 (0.26%)

108.49 -0.30 (-0.28%)

127.16 -0.03 (-0.02%)

0.61 0.00 (-0.36%)